This is the first neural imaging study to use regional cerebral blood flow (rCBF) in an animal model to identify the patterns of forebr nociceptive processing that occur during the early and late phase of the formalin test. We measured normalized rCBF increases by autoradiographic method using the radiotracer [ 99m Tc]exametazime. Noxious formalin consistently produced detectable, well-localized a typically bilateral increases in rCBF within multiple forebrain structures, as well as the interpeduncular nucleus (Activation Index, AI = 6 and the midbrain periaqueductal gray (AI = 20). Structures showing pain-induced changes in rCBF included several forebrain regio considered part of the limbic system. The hindlimb region of somatosensory cortex was significantly activated (AI = 31), and blood fl increases in VPL (AI = 8.7) and the medial thalamus (AI = 9.0) exhibited a tendency to be greater in the late phase as compared to the ea phase of the formalin test. The spatial pattern and intensity of activation varied as a function of the time following the noxious forma stimulus. The results highlight the important role of the limbic forebrain in the neural mechanisms of prolonged persistent pain and prov evidence for a forebrain network for pain.
Introduction
The formalin test is a widely used animal model for prolonged acute pain which is based upon injection of dilute formalin solution, usually into the subcutaneous tissue of one paw (Dubuisson and Dennis, 1977; Tjolsen et al., 1992) This algogenic stimulus elicits three prominent behavioral responses commonly assumed to indicate the presence of pain (Dubuisson and Dennis, 1977; Wheeler Aceto and Cowan, 1991; Abbott et al., 1995) . Following a formalin injection, the paw is lifted or favored, licked and sometimes bitten and shaken, with the intensity of these behavioral responses proportional to the concentration of forma used in the test. This stimulus differs from convention phasic pain stimuli in that it produces a mild tissue inju (Dubuisson and Dennis, 1977; Wheeler Aceto and Cowa 1991; Tjolsen et al., 1992; Abbott et al., 1995) . During t first (early) phase, which starts immediately after injecti of formalin, pain behaviors are frequently elicited and a most intense. This phase continues for approximately 5 m after which nociception is considerably reduced. The se ond (late) phase is marked by the return of moderate to hi levels of pain-related behaviors beginning 10 to 15 min af formalin injection. These late phase pain-related behavio can persist for up to 1 h or more depending on the conce tration of formalin used as the noxious stimulus. The ea phase is thought to be due to a direct activation of periphe nociceptors by formalin; whereas the late phase is believ to be related to the development of inflammation and sen
